Cambridge Enterprise and Qkine to drive stem cell and regenerative medicine research

Cambridge Enterprise, the commercialisation arm of the University of Cambridge, and specialist growth factor manufacturer Qkine Ltd have signed a key licensing deal for Activin A production technology. Qkine is a recent spin-out from the university.

About the author: saw100

Leave a Reply

Your email address will not be published.